Studies presented here demonstrate that individually expanded clones of murine Ly-1 B cells, perhaps analogous to the expanded neoplastic Leu-1 B-cell clones in human chronic lymphocytic leukemias, are universally detectable in young New Zealand Black (NZB)-related autoimmune mice and in senescent normal mice (>18 months old). These clones are visible as phenotypically homogeneous cell populations in multiparameter fluorescence-activated cell sorter analyses of peritoneal and splenic B cells; they show unique immunoglobulin heavy-and light-chain gene rearrangements in Southern gel analyses of peritoneal and splenic DNA; and, like the self-replenishing Ly-1 B-cell population from which they are drawn, they tend to grow readily in irradiated or unirradiated syngeneic or allotype congenic hosts. Furthermore, they develop and generalize in primary and secondary hosts in a characteristic pattern (peritoneum >> spleen > lymph node > bone marrow) that suggests that their initial growth is controlled by the mechanisms that normally control Ly-1 B-cell distribution in lymphoid organs. The universal emergence of these clones within the Ly-1 B-cell lineage may be explained by the substantially greater opportunity for hyperplastic and neoplastic transformation events in this long-lived self-replenishing Ly-1 B-cell population, which must divide relatively frequently to maintain its normal size throughout adulthood. Repeated exposure to internal or environmental antigens (with which Ly-1 B cells are known to react) may also play a role in driving the development of these clones.
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Recent studies divide murine B lymphocytes into two lineages: the conventional B-cell lineage, which is replenished from surface immunoglobulin-negative progenitors in the bone marrow; and the Ly-1 B lineage (Ly-1 B), which in the adult is a self-renewing population replenished from immunoglobulin-positive progenitors found largely in the peritoneal cavity (1) (2) (3) . Ly-1 B cells normally comprise only 1-3% of splenic B cells; however, they constitute 40-80% of the B cells in the peritoneum (1) (2) (3) . They can express two surface antigens not found on conventional murine B cells, CD5 (Ly-1) (1, 4) and CD11 (MAC-1) (5). In addition, recent studies have shown that within the Ly-1 B-cell lineage two populations exist that can be distinguished by their expression of the CD5 (Ly-1) antigen (ref. 1; A.M.S., unpublished observation). The CD5 + Ly-1 lineage B cells and the CD5 -Ly-1 B cells (also referred to as the sister population) are, except for the expression of the CD5 antigen, phenotypically, developmentally, and functionally indistinguishable. Homologous antigens Leu-1 (CD5) (6) and (CD11) (7) are expressed on human Leu-1 B cells.
At the functional level, Ly-1 lineage B cells produce many of the autoantibodies found in normal and New Zealand Black (NZB)-related autoimmune mice (4); in addition, Ly-1 B-cell frequencies are much higher in autoimmune NZB and (NZB x NZW)F1 (B/W) than in normal mouse strains (8) (NZW, New Zealand White). Similarly, the homologous population in humans (Leu-1 B cells) have been shown to produce certain autoantibodies-e.g., IgM rheumatoid factor (9, 10)-and are increased in frequency in some autoimmune diseases (10, 11) . The autoimmune disease in B/W mice has been studied for years as a murine model for human systemic lupus erythematosus (12, 13) .
We report here that NZB-related mice have an additional and perhaps related immunological defect: they uniformly develop clonal populations of self-perpetuating Ly-1 B cells that arise in the peritoneal cavity early in life and eventually invade all lymphoid tissues. We also show that similar clonal Ly-1 B-cell populations can be detected in older mice (>15 months old) of all strains. The phenotypic and growth characteristics of these clonal populations suggest that they represent the murine equivalent of human B-cell chronic lymphocytic leukemia (B-CLL).
MATERIALS AND METHODS Animals. Two-month-old NZB, NZW, and B/W female mice were obtained from The Jackson Laboratories and maintained at Stanford. All other mice were bred in the Stanford Department of Genetics Mouse Facility.
Fluorescence-Activated Cell Sorter (FACS) Analysis. Single cell suspensions were prepared from lymphoid organs as described (14) and stained with optimal amounts of monoclonal antibodies: anti-IgM, 331.12/fluorescein isothiocyanate; anti-CD5 (Ly-1), 53.7/allophycocyanin; anti-IgD, AMS 15.1/biotin; anti-B220/6B2, RA3-6B2/biotin. Purification and fluorochrome conjugation of the monoclonal antibodies have been described in detail (5, 15) . Biotin-conjugated antibodies were revealed with Texas Red avidin. FACS analyses were conducted as described (5, 16) . Dead cells were stained with propidium iodide and excluded from the analyses (16) . For each analysis, data from 30,000 viable cells were collected. Data are presented as 5% probability contour maps (17 This generalization from the peritoneum follows a characteristic pattern in that the clonal populations initially maintain Ly-1 B tissue specificity but eventually become invasive and expand into tissues in which Ly-1 B cells are not normally found. Clones first become detectable (by FACS analysis) in spleen and peripheral blood, where Ly-1 B cells are rare but always present. In some animals, clones then emerge 2-3 months later in lymph nodes and bone marrow even though Ly-1 B cells are not normally detectable in these organs (1) (Fig. 3) . Clonal expansion outside the spleen and peritoneal cavity, however, appears to proceed relatively slowly. For example, the Ly-1 B clone present in the bone marrow of an 11-month-old mouse represents <1% of nucleated cells in the bone marrow (Fig. 3) . Similarly, while Ly-1 B-cell clones are readily apparent in the peripheral blood of 7-month-old mice (Fig. 3) and gradually increase over time, the overall blood lymphocyte counts in B/W mice do not reach leukemic levels Spleen at 8-12 months of age when these mice typically die from autoimmune disease. B/W mice that survive longer, however, do become leukemic, since Ly-1 B frequencies in the blood of 2-year-old animals in which the autoimmune disease is reversed by anti-L3T4 treatment increase as much as 40-fold above normal (21) .
Splenic or peritoneal Ly-1 B clones can be transferred indefinitely in irradiated or nonirradiated syngeneic or allotype congenic recipients. As shown in Fig. 4 , the phenotypes of individual Ly-1 B clones remain relatively stable after transfer, although individual populations may expand at different rates. The donor origin ofthe Ly-1 B-cell clones was confirmed by Southern analysis. The same clonal JH rearrangement bands were present in the analysis of pre-and 7-month posttransfer peritoneal samples (data not shown).
Early Development of Ly-1 B Clonal Populations Is Characteristic of All New Zealand-Related Strains of Mice (NZB, NZW, and B/W). Ly-1 B-cell clones develop in both B/W parental strains-i.e., NZB (22) and NZW (Fig. 1) 
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